DrugPatentWatch Database Preview
Cadila Company Profile
» See Plans and Pricing
What is the competitive landscape for CADILA, and what generic and branded alternatives to CADILA drugs are available?
CADILA has fifty-five approved drugs.
There is one tentative approval on CADILA drugs.
Summary for Cadila
| US Patents: | 0 |
| Tradenames: | 46 |
| Ingredients: | 46 |
| NDAs: | 55 |
| Patent Litigation for Cadila: | See patent lawsuits for Cadila |
Drugs and US Patents for Cadila
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cadila Pharms Ltd | HYDRALAZINE HYDROCHLORIDE | hydralazine hydrochloride | TABLET;ORAL | 203845-001 | Sep 18, 2014 | AA | RX | No | No | Start Trial | Start Trial | ||||
| Cadila Pharms Ltd | FLUOXETINE HYDROCHLORIDE | fluoxetine hydrochloride | CAPSULE;ORAL | 206993-002 | May 23, 2019 | AB1 | RX | No | No | Start Trial | Start Trial | ||||
| Cadila Pharms Ltd | RIVASTIGMINE TARTRATE | rivastigmine tartrate | CAPSULE;ORAL | 203844-004 | Feb 13, 2017 | AB | RX | No | No | Start Trial | Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
